News

Vedanta Biosciences, a clinical-stage company developing a new category of therapies for immune-mediated diseases based on rationally-defined consortia of human microbiome-derived…
Read More...

Catalent Pharma Solutions announced that work to expand its primary packaging capabilities at its clinical facility in Shanghai, China has reached the commissioning stage and is…
Read More...

Aileron Therapeutics announced that it has entered into a clinical trial collaboration with Pfizer to evaluate the combination of Aileron’s ALRN-6924 and Pfizer’s palbociclib, also…
Read More...

Evelo Biosciences announced that it has entered into a clinical trial collaboration agreement with Merck (known as MSD outside the US and Canada). The collaboration will evaluate…
Read More...

Sandoz, a Novartis division and the pioneer and global leader in biosimilars, announced that the European Commission (EC) granted marketing authorization for biosimilar Ziextenzo …
Read More...

Jecure Therapeutics Inc., a biotechnology company with novel drug discovery programs targeting serious inflammatory diseases, announced a definitive agreement by which it will be…
Read More...

AiPing Pharmaceutical, Inc. announced that it has completed the sale of three ibuprofen Abbreviated New Drug Applications (ANDAs) in the U.S. to Shandong Xinhua Pharmaceutical Co., Ltd.…
Read More...

Octapharma announced that the Swiss Agency for Therapeutic Products, Swissmedic, granted marketing authorization to its new fibrinogen concentrate product fibryga for the treatment of…
Read More...

CBT Pharmaceuticals (CBT) and Zhejiang Bossan Pharmaceutical Co., Ltd (Bossan) announced that they have entered into a clinical collaboration and license agreement to develop their…
Read More...

Edge Therapeutics and PDS Biotechnology Corporation announced that their respective boards of directors have approved a definitive merger agreement. The merger is expected to create a…
Read More...

Telix Pharmaceuticals Limited has announced the acquisition of Belgium-based Advanced Nuclear Medicine Ingredients (ANMI) SA for €5.15m in cash and shares. The acquisition of ANMI…
Read More...

Fusion Antibodies plc, experts in antibody engineering and Analytics Engines, an advanced data analytics company, have announced a strategic collaboration to incorporate machine…
Read More...

Vir Biotechnology, Inc. and Alnylam Pharmaceuticals, Inc. announced the initiation of a Phase 1/2 study of VIR-2218, a novel, investigational RNA interference (RNAi) therapeutic for the…
Read More...

Machavert Pharmaceuticals, a drug development company focused on bioactive phospholipid therapeutics for the treatment of cancer, recently reported impressive preclinical results. The…
Read More...

AstraZeneca announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for Fasenra (benralizumab) for the treatment of Eosinophilic…
Read More...

The Mundipharma network of independent associated companies announced that the European Commission (EC) has granted approval for the use of Pelmeg (pegfilgrastim) as a treatment for…
Read More...

Shanghai Roche Pharmaceuticals and Ascletis BioScience jointly announce that starting from 1st Dec 2018, Ascletis and Roche will expand their partnership in viral Hepatitis. Following…
Read More...

Danish dermatology specialists LEO Pharma and California rare disease pioneers PellePharm announced a strategic development and commercialization collaboration to address unmet medical…
Read More...

OBI Pharma, Inc., a Taiwan biopharma company announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for OBI-888 for the treatment of Pancreatic…
Read More...

WuXi Biologics announced that construction of a global innovation center has commenced in the district of Fengxian in Shanghai. The new state-of-the-art biologics center will…
Read More...